Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
Clinical trial NCT02677298 · COMPLETED
Trial details
- NCT number
- NCT02677298
- Sponsor
- Croma-Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-02
- Primary completion
- 2016-11-23
- Enrollment
- 784
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.